To Pay Down Debt, Walgreens Sells More Cencora Shares For $300 Million
Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...
Walgreens Boots Alliance sells $314 million in Cencora stock
Walgreens Boots Alliance, Inc. (NASDAQ:WBA), through its subsidiary Walgreens Boots Alliance Holdings LLC, recently reported significant stock transactions involving Cencora, Inc. (NYSE:COR), a ...
Healthcare Dive4d
Walgreens offloads more Cencora shares
The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...
Crain's Chicago Business4d
Walgreens injecting $300M in another Cencora sell-off, early settlement
In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...
Walgreens sells more shares in Cencora; cuts stake to 6%
U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for ...
Leerink Partnrs Brokers Boost Earnings Estimates for Cencora
Equities researchers at Leerink Partnrs lifted their Q3 2025 earnings estimates for Cencora in a research report issued on ...
Becker's Hospital Review4d
Cencora expands Sure Supply Program, adds 200 critical medications amid shortages
Cencora, a global healthcare company, has expanded its Sure Supply Program to include 200 critical medications, including several oncology treatments, in response to ongoing drug shortages. This marks ...
ETF Daily News4d
Cencora, Inc. (NYSE:COR) Given Consensus Rating of “Moderate Buy” by Brokerages
Cencora, Inc. (NYSE:COR – Get Free Report) has received an average recommendation of “Moderate Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports.
Drug Store News4d
Cencora announces common share repurchase from WBA
Cencora said it intends to repurchase shares from WBA at the price per share equal to the price in the Rule 144 sale.